Schreiber A - Search Results

1

Characterization of α-taxilin as a novel factor controlling the release of hepatitis C virus.

Elgner F, Donnerhak C, Ren H, Medvedev R, Schreiber A, Weber L, Heilmann M, Ploen D, Himmelsbach K, Finkernagel M, Klingel K, Hildt E. Elgner F, et al. Among authors: schreiber a. Biochem J. 2016 Jan 15;473(2):145-55. doi: 10.1042/BJ20150717. Epub 2015 Nov 2. Biochem J. 2016. PMID: 26527738

2

Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model.

Laure M, Hamza H, Koch-Heier J, Quernheim M, Müller C, Schreiber A, Müller G, Pleschka S, Ludwig S, Planz O. Laure M, et al. Among authors: schreiber a. Antiviral Res. 2020 Jun;178:104806. doi: 10.1016/j.antiviral.2020.104806. Epub 2020 Apr 15. Antiviral Res. 2020. PMID: 32304723 Free article.

3

The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.

Schreiber A, Viemann D, Schöning J, Schloer S, Mecate Zambrano A, Brunotte L, Faist A, Schöfbänker M, Hrincius E, Hoffmann H, Hoffmann M, Pöhlmann S, Rescher U, Planz O, Ludwig S. Schreiber A, et al. Cell Mol Life Sci. 2022 Jan 10;79(1):65. doi: 10.1007/s00018-021-04085-1. Cell Mol Life Sci. 2022. PMID: 35013790 Free PMC article.

4

The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo.

Haasbach E, Müller C, Ehrhardt C, Schreiber A, Pleschka S, Ludwig S, Planz O. Haasbach E, et al. Among authors: schreiber a. Antiviral Res. 2017 Jun;142:178-184. doi: 10.1016/j.antiviral.2017.03.024. Epub 2017 Apr 2. Antiviral Res. 2017. PMID: 28377100 Free article.

5

The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression.

Schräder T, Dudek SE, Schreiber A, Ehrhardt C, Planz O, Ludwig S. Schräder T, et al. Among authors: schreiber a. Antiviral Res. 2018 Sep;157:80-92. doi: 10.1016/j.antiviral.2018.07.006. Epub 2018 Jul 7. Antiviral Res. 2018. PMID: 29990517 Free article.

6

Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes.

Schreiber A, Boff L, Anhlan D, Krischuns T, Brunotte L, Schuberth C, Wedlich-Söldner R, Drexler H, Ludwig S. Schreiber A, et al. Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16557-16566. doi: 10.1073/pnas.2002828117. Epub 2020 Jun 29. Proc Natl Acad Sci U S A. 2020. PMID: 32601201 Free PMC article.

7

Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2.

Hoffmann H, Ebensperger M, Schönsiegel A, Hamza H, Koch-Heier J, Schreiber A, Ludwig S, Schindler M, Planz O. Hoffmann H, et al. Among authors: schreiber a. Front Cell Infect Microbiol. 2023 Oct 26;13:1264983. doi: 10.3389/fcimb.2023.1264983. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37965261 Free PMC article.

8

Type I interferon antagonistic properties of influenza B virus polymerase proteins.

Schreiber A, Liedmann S, Brunotte L, Anhlan D, Ehrhardt C, Ludwig S. Schreiber A, et al. Cell Microbiol. 2020 Feb;22(2):e13143. doi: 10.1111/cmi.13143. Epub 2019 Dec 8. Cell Microbiol. 2020. PMID: 31711273

9

Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assembly.

Mecate-Zambrano A, Sukumar S, Seebohm G, Ciminski K, Schreiber A, Anhlan D, Greune L, Wixler L, Grothe S, Stein NC, Schmidt MA, Langer K, Schwemmle M, Shi T, Ludwig S, Boergeling Y. Mecate-Zambrano A, et al. Among authors: schreiber a. PLoS Pathog. 2020 Aug 31;16(8):e1008775. doi: 10.1371/journal.ppat.1008775. eCollection 2020 Aug. PLoS Pathog. 2020. PMID: 32866218 Free PMC article.

10

Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier.

Faist A, Schloer S, Mecate-Zambrano A, Janowski J, Schreiber A, Boergeling Y, Conrad BCG, Kumar S, Toebben L, Schughart K, Baumgardt M, Kessler M, Hoenzke K, Hocke A, Trautmann M, Hartmann W, Kato H, Rescher U, Christersson A, Kuehn J, Mellmann A, Wolff T, Kuempers P, Rovas A, Wiewrodt R, Wiebe K, Barth P, Ludwig S, Brunotte L. Faist A, et al. Among authors: schreiber a. Antiviral Res. 2023 Jan;209:105475. doi: 10.1016/j.antiviral.2022.105475. Epub 2022 Nov 21. Antiviral Res. 2023. PMID: 36423831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,078 results

Search Page